北京市中伦（广州）律师事务所 关于金发拉比妇婴童用品股份有限公司 2025 年第二次临时股东大会的法律意见书 致：金发拉比妇婴童用品股份有限公司 北京市中伦（广州）律师事务所（以下简称"本所"）受金发拉比妇婴童用 品股份有限公司（以下简称"公司"）委托，指派本所律师叶可安、刘杰（以下 简称"本所律师"）出席公司 2025 年第二次临时股东大会（以下简称"本次股 东大会"）。本所律师根据《中华人民共和国公司法》（以下简称"《公司法》"）、 《上市公司股东会规则》等有关法律、法规、规范性文件及《金发拉比妇婴童用 品股份有限公司章程》（以下简称"《公司章程》"）的规定，对公司本次股东 大会进行见证并出具法律意见。 为出具本法律意见书，本所律师审查了公司本次股东大会的有关文件和材料。 本所律师得到公司如下保证，即其已提供了本所律师认为作为出具本法律意见书 所必需的材料，所提供的原始材料、副本、复印件等材料、口头证言均符合真实、 准确、完整的要求，有关副本、复印件等材料与原始材料一致。 在本法律意见书中，本所律师仅对本次股东大会的召集、召开程序、出席本 次股东大会人员和召集人的资格、会议表决程序及表决结果是否符合《公司 ...

Core Viewpoint - The stock price of Jinfa Labi has shown significant volatility despite a substantial increase in revenue, leading to confusion among industry experts regarding the company's financial health and future prospects [1][2][3]. Financial Performance - In the first half of 2025, Jinfa Labi achieved a revenue of 158 million yuan, representing a year-on-year growth of 101.99% [1]. - The revenue from maternal and infant products was 123 million yuan, accounting for 77.64% of total revenue, with a year-on-year increase of 62.34% [1]. - The medical beauty segment generated 33 million yuan, contributing to 21.03% of total revenue, with a year-on-year growth of 100% [1][2]. Cost and Profitability - The company's operating costs surged to 100 million yuan, a year-on-year increase of 183.11%, primarily due to the expansion of e-commerce channels and the consolidation of the medical beauty business [2]. - Sales expenses rose by 72.52% to 37.78 million yuan, while management expenses increased by 11.45% to 20.19 million yuan [2]. - Jinfa Labi reported a net loss attributable to shareholders of 17.92 million yuan, worsening from a loss of 2.75 million yuan in the same period of 2024 [2][5]. Market Dynamics - The stock price fluctuations are influenced by market sentiment and speculative trading, particularly in light of government policies promoting childbirth and the growth of the maternal and infant sectors [3]. - The integration of the medical beauty business is seen as a strategic move to create a dual growth engine alongside maternal and infant products, which has garnered market interest [3][5]. Company History and Challenges - Jinfa Labi, listed in June 2015, has faced a prolonged period of declining profits, with significant losses reported in recent years, raising concerns about its potential delisting [4]. - The company has seen a reduction in its store count from 1,133 in 2019 to 587 in 2024, indicating operational challenges [4].

New Stock Offerings - Fushun Special Steel (600399) is undergoing a tender offer period from August 12, 2025, to September 10, 2025[1] - *ST Tianmao (000627) has a cash option declaration period from September 15, 2025, to September 19, 2025[1] - Tianpu Co., Ltd. (605255) has announced its latest updates on September 4, 2025[1] Market Alerts - Kaipu Cloud (688228) has reported severe abnormal fluctuations as of August 30, 2025[1] - Siquan New Materials (301489) and Xinhua Jin (600735) also reported significant market movements on August 22 and August 30, 2025, respectively[1] - Multiple companies including *ST Baoying (002047) and Wantong Development (600246) have updates as of September 4, 2025[1] Trading Notifications - A total of 30 companies have issued trading notifications with specific dates for announcements and updates, indicating active market participation[1] - The report includes links to detailed announcements for each company, ensuring transparency and accessibility of information[1]

金发拉比妇婴童用品股份有限公司（以下简称"公司"）股票（证券简称：*ST 金 比，股票代码：002762）交易价格连续三个交易日（2025 年 9 月 1 日、2025 年 9 月 2 日、2025 年 9 月 3 日）收盘价格涨幅偏离值累计超过 12%，根据《深圳证券交易所股票 上市规则》的相关规定，属于股票交易异常波动情况。 二、对重要问题的关注、核实情况 证券代码：002762 证券简称：*ST金比 公告编号：2025-052号 金发拉比妇婴童用品股份有限公司 股票交易异常波动公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 一、股票交易异常波动的情况介绍 三、是否存在应披露而未披露信息的说明 公司董事会确认，公司目前没有任何根据《深圳证券交易所股票上市规则》等有关 规定应予以披露而未披露的事项或与该事项有关的筹划、商谈、意向、协议等；董事会 也未获悉本公司有根据《深圳证券交易所股票上市规则》等有关规定应予以披露而未披 露的、对本公司股票及其衍生品种交易价格产生较大影响的信息；公司前期披露的信息 不存在需要更正、补充之处。 四、公司认为必要的风险提示 ...

证券代码：002762 证券简称：*ST金比 公告编号：2025-051号 金发拉比妇婴童用品股份有限公司 关于担保续期事项的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 一、担保续期情况概述 金发拉比妇婴童用品股份有限公司（以下简称"公司"）于 2024 年 4 月 18 日披露 了《关于 2024 年度对外担保额度预计的公告》（2024-017 号），2024 年 7 月 18 日披 露了《关于调整对外担保事项的公告》（2024-031 号）。公司分别于 2025 年 6 月 30 日、2025 年 7 月 18 日召开了第五届董事会第十八次会议和 2025 年第一次临时股东大会， 审议通过了《关于 2025 年度为关联参股公司进行续期担保的议案》，同意公司在 2025 年度为关联参股公司——广东韩妃医院投资有限公司（以下简称"韩妃投资"）之子公 司——广东韩妃整形外科医院有限公司（以下简称"广东韩妃"）向银行等相关金融机 构的融资提供总计不超过人民币 3000 万元的担保额度续期，最高担保额度占公司最近 一期经审计净资产的 3.43%。公司股 ...

Core Viewpoint - *ST Jinbi reported significant revenue growth but continued to incur losses, indicating challenges in profitability despite increased sales [1] Financial Performance - The total revenue for the first half of 2025 reached 158 million yuan, a year-on-year increase of 101.99% [1] - The net profit attributable to shareholders was -17.92 million yuan, a decline of 550.84% compared to the previous year [1] - In Q2 2025, total revenue was 82.01 million yuan, up 135.96% year-on-year, while net profit was -15.75 million yuan, down 385.87% [1] - Gross margin decreased to 36.49%, down 33.28% year-on-year, and net margin was -10.37%, a drop of 185.56% [1] - Total expenses (selling, administrative, and financial) amounted to 57.74 million yuan, accounting for 36.53% of revenue, a decrease of 28.26% year-on-year [1] Cash Flow and Debt - The company reported cash and cash equivalents of 99.44 million yuan, an increase of 55.81% year-on-year [1] - Accounts receivable rose to 24.60 million yuan, up 109.47% year-on-year [1] - Interest-bearing liabilities surged to 33.48 million yuan, an increase of 813.49% compared to the previous year [1] - Operating cash flow per share was -0.01 yuan, a decrease of 203.27% year-on-year [1] Business Model and Operational Insights - The company's return on invested capital (ROIC) was 5.72% last year, indicating average capital returns [3] - The historical median ROIC since listing is 6.61%, with a notably poor ROIC of -9.7% in 2022 [3] - The business model relies heavily on marketing, necessitating a deeper analysis of the underlying drivers [4]

Core Points - The company held its 20th meeting of the 5th Board of Directors on August 26, 2025, with 7 directors present, confirming the meeting's legality and effectiveness [1][2] - The company approved the 2025 Half-Year Report and its summary, which can be found on designated information disclosure platforms [1] - The company passed a resolution to recognize historical financial assistance constituted by passive financial interactions with subsidiaries and affiliated companies, requiring submission to a temporary shareholders' meeting for further approval [2] - The company also approved the notice for the 2025 Second Temporary Shareholders' Meeting [2]

Group 1 - The company held the 17th meeting of the 5th Supervisory Board on August 26, 2025, with all three supervisors present, confirming the meeting's legality and validity [1][2] - The Supervisory Board unanimously approved the 2025 semi-annual report and summary, stating that the report accurately reflects the company's actual situation without any false records or misleading statements [1] - The Supervisory Board also approved a proposal to recognize historical financial assistance constituted by passive financial interactions between subsidiaries and associated companies [1]

Meeting Announcement - The company, Jinfa Labi Maternal and Child Products Co., Ltd., will hold its second extraordinary general meeting of shareholders in 2025 on September 11, 2025 [1][2] - The meeting will be conducted in a hybrid format, combining on-site voting and online voting [2][3] Voting Details - On-site meeting will take place at 14:30 on September 11, 2025, at the company's conference room in Shantou City [1] - Online voting will be available through the Shenzhen Stock Exchange trading system from 9:15 to 9:25, 9:30 to 11:30, and 13:00 to 15:00 on the same day [2] - Internet voting will be accessible from 9:15 to 15:00 on September 11, 2025 [2] Attendance and Registration - All shareholders registered with the China Securities Depository and Clearing Corporation Limited as of September 4, 2025, are entitled to attend the meeting [2][3] - Shareholders can appoint proxies to attend and vote on their behalf, with specific documentation required for both corporate and individual shareholders [3][4] Agenda Items - The meeting will review non-cumulative voting proposals, including a proposal related to financial assistance [3][7] - Detailed information regarding the proposals will be published in relevant financial newspapers and online platforms [3] Contact Information - For inquiries, shareholders can contact Xue Ping'an or Su Yucan via phone or email [4]

Group 1 - The core point of the article highlights the announcement by *ST Jinbi regarding its board meeting and the composition of its revenue for 2024, indicating a strong focus on the maternal and infant consumer goods sector [1][1][1] - The company reported that 97.27% of its revenue in 2024 will come from the maternal and infant consumer goods industry, with only 2.73% from other sources [1][1][1] - As of the report, *ST Jinbi has a market capitalization of 2.3 billion yuan [1][1][1] Group 2 - The article also mentions a significant growth opportunity in the pet industry, which is projected to reach a market size of 300 billion yuan, indicating a booming sector for related companies [1][1][1] - The news suggests that companies in the pet industry are experiencing a surge in stock prices, reflecting positive market sentiment [1][1][1]